Regenxbio (RGNX) EBITDA Margin Growth (5y) (2019 - 2025)
Regenxbio (RGNX) EBITDA Margin Growth (5y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Regenxbio | 528.62 Mn | 298.55 Mn | 21.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3,788.00 |
| Sep 30, 2025 | -19,038.00 |
| Jun 30, 2025 | -4,374.00 |
| Mar 31, 2025 | 22,760.00 |
| Dec 31, 2024 | 10,052.00 |
| Sep 30, 2024 | -1,236.00 |
| Jun 30, 2024 | 21,135.00 |
| Mar 31, 2024 | 364,556.00 |
| Dec 31, 2023 | -29,369.00 |
| Sep 30, 2023 | 20,362.00 |
| Jun 30, 2023 | -38,182.00 |
| Mar 31, 2023 | -42,275.00 |
| Dec 31, 2022 | 62,932.00 |
| Sep 30, 2022 | 132,701.00 |
| Jun 30, 2022 | 3,791.00 |
| Mar 31, 2022 | 471,587.00 |
| Dec 31, 2021 | 128,556.00 |
| Sep 30, 2021 | 1.47 Mn |
| Jun 30, 2021 | 39,254.00 |
| Mar 31, 2021 | 262,963.00 |